Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Nov 19, 2025, 09:17 ET Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions
models, ensuring versatility for critical research and development needs. In addition, for antibody production, Tsingke uses Expi293 and CHO-K1 systems, achieving milligram-scale yields in 7 days and gram-scale yields in 14 days, with average production
More news about: Beijing Tsingke Biotech Co., Ltd.
Nov 19, 2025, 09:17 ET Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions
models, ensuring versatility for critical research and development needs. In addition, for antibody production, Tsingke uses Expi293 and CHO-K1 systems, achieving milligram-scale yields in 7 days and gram-scale yields in 14 days, with average production
More news about: Beijing Tsingke Biotech Co., Ltd.